WASHINGTON — Hundreds of millions of dollars worth of fentanyl — and likely more — is pouring into the United States through international mail — and the federal government isn’t equipped to track it or prevent it from happening, according to a nearly yearlong bipartisan Senate investigation.

The 100-page report, released Wednesday from Sens. Rob Portman (R-Ohio) and Tom Carper (D-Del.) and conducted by the Senate’s permanent subcommittee on investigations, looked at just six online sellers offering fentanyl — the powerful opioid implicated in a growing number of overdose deaths. Five are based in China; investigators could not confirm the location of the sixth.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • Online intelligence briefings
  • Frequent opportunities to engage with veteran beat reporters and industry experts
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Leave a Comment

Please enter your name.
Please enter a comment.

  • So why is the USPS not complying with the the security prior to China shipping into our country I wish to invoke the whistle blowers protection act

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy